Idexx Laboratories Latin America & Caribbean — Total consolidated revenue decreased by 7.4% to $23.22M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.2%, from $19.99M to $23.22M. Over 4 years (FY 2021 to FY 2025), Latin America & Caribbean — Total consolidated revenue shows an upward trend with a 7.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful market expansion, higher adoption of diagnostic products, or improved pricing power in the region, while a decrease may signal competitive pressure or economic headwinds in these specific markets.
This metric represents the total gross sales generated from products and services sold within the Latin American and Car...
Peers in the veterinary or medical diagnostics space typically report regional revenue to track geographic diversification and exposure to emerging market growth cycles.
idxx_segment_latin_america_caribbean_total_consolidated_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.39M | $17.07M | $17.58M | $17.74M | $19.10M | $18.69M | $19.51M | $19.45M | $20.82M | $21.35M | $22.30M | $20.24M | $21.32M | $20.98M | $21.15M | $19.99M | $22.33M | $23.04M | $25.06M | $23.22M |
| QoQ Change | — | +4.1% | +3.0% | +0.9% | +7.6% | -2.1% | +4.3% | -0.3% | +7.0% | +2.6% | +4.5% | -9.3% | +5.3% | -1.6% | +0.8% | -5.5% | +11.7% | +3.2% | +8.8% | -7.4% |
| YoY Change | — | — | — | — | +16.5% | +9.5% | +10.9% | +9.6% | +9.0% | +14.2% | +14.4% | +4.1% | +2.4% | -1.7% | -5.2% | -1.3% | +4.7% | +9.8% | +18.5% | +16.2% |